A Kaplan–Meier-survival analysis showed a significant benefit for patients with a higher abundance of CD8 TEM GZMK cells (Supplementary Fig. 4G), suggesting their involvement in CLL control. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.